Keeping you up to date on recent developments in orthopedics, including: Long-term risks of joint implants; New approach to treating osteoarthritis advances; Osmotic therapy device reduces swelling to prevent secondary injuries in rats.
Keeping you up to date on recent developments in orthopedics, including: Implanted neural stem cell grafts show functionality in spinal cord injuries; Silk scaffolds and magnetism to generate bone tissue and be able to use it in implants; Hydrogel paves way for biomedical breakthrough; New strategy against osteoporosis.
Orthopedic companies felt pressure from COVID-19 in their most recent quarters. For example, Zimmer Biomet Holdings Inc. reported second-quarter net sales of $1.226 billion, a decrease of 38.3% from the prior-year period. Still, those revenues did come ahead of expectations, as Wells Fargo analyst Larry Biegelsen noted – $432 million ahead of his group's estimate and $305 million ahead of consensus.
A bioelectronic platform that stimulates the vagus nerve to reduce inflammatory activity and restore balance in the immune system is the ultimate aim of Setpoint Medical Inc. The Valencia, Calif.-based startup is preparing to start a U.S. pivotal trial for its most advanced program in rheumatoid arthritis (RA) later this year or early next.
Keeping you up to date on recent developments in orthopedics, including: Lego-inspired bone and soft tissue repair with tiny, 3D-printed bricks; Mutant zebrafish reveals a turning point in spine's evolution; Newly discovered cells act as a warning signal for rheumatoid arthritis flares.
Keeping you up to date on recent developments in orthopedics, including: Spinal stimulators repurposed to restore touch in lost limb; Genetic testing could improve screening for osteoporosis; Study shows genetic markers are useful in predicting osteoporotic fracture risk.
Bone fracture repair startup Curvafix Inc. has secured $10.75 million in a series B round led by Sectoral Asset Management with participation from existing investors, including Delta Dental Washington Seed Fund, as well as board members. The company will use the proceeds to complete the RESTORE clinical trial of its U.S. FDA-cleared Curvafix intramedullar rodscrew and to scale up for commercial launch later this year or in 2021.
Medtronic plc said Wednesday it will purchase Medicrea Group, a French manufacturer of patient-specific 3D printed spinal implants, in a step to further strengthen its spine surgery business. The friendly, all-cash offer is priced at €7 (US$7.98) for each Medicrea share, a 22% over its July 14 closing price. The total value of the deal is approximately €200 million (about US$228 million), which includes roughly €50 million in net cash and liabilities plus about €150 million in equity. Medtronic expects to close the deal by the end of the year, pending regulatory nods in France and the U.S.
Keeping you up to date on recent developments in orthopedics, including: Primitive stem cells point to new bone grafts for stubborn-to-heal fractures; Orthopedic surgeons issue guidelines on resuming elective surgery amid COVID-19 pandemic; Cardiac CT can double as osteoporosis test; Novel bone imaging approach provides insights into the progression of knee osteoarthritis.
Keeping you up to date on recent developments in orthopedics, including: Buzzing to rebuild broken bone; Tiny mineral particles are better vehicles for promising gene therapy; New trial results question standard treatment plan for rheumatoid arthritis.
RSS
